RUSSIAN CORONA VIRUS VACCINES


russian coronavirus vaccines
russian coronavirus vaccines



The latest breaking news this Sunday is that a university in Russia has discovered a vaccine against the coronavirus and they are saying that this vaccine is very useful to overcome the corona threat.

A university in Russia has also reported that the vaccine was the first and most successful treatment for humans. Eventually Russia will be the first vaccine discovered on the corona.


Exactknow-how.com is here to help you learn something completely new, here we are always with you.



 The news, which broke the internet, became the first country to complete clinical trials of the Kovid-19 vaccine on humans, and the results proved drug effect, media reported Sunday.

Elena Smolyarkuk, chief researcher at the Center for Clinical Research on Medicine at Sechinov University, told Russian news agency TASS on Sunday that human tests for the vaccine had been completed at the university and would be released soon.

corona virus vaccine found at russia


In a report to Smolarchuk, he said, "Research has been completed and the vaccine has been proven to be safe. Volunteers will be released on July 15 and July 20."

However, no further information has been given about the vaccine entering the commercial production phase.

In India, 850K cases of malignant infections have been reported so far in the country, but more than 22K have lost the war with Kovid-19.


Russian coronavacin
Several reports on Sunday said that Sechinov of a Russian university had completed clinical trials of the vaccine for a novel coronavirus, similar to the world's first vaccine to treat human corals.

According to the Russian news agency Toss, the "clinical trial" of the COVID-19 vaccine tested by the University of Kochinov was completed: the first phase of research on the vaccine began on June 18, when a team of 18 volunteers was hired, and on June 23 a team of 20 volunteers is vaccinating on stage.


Russian corona vaccine


The most quoted report published in Sputnik News‌ states that the clinical trial of "the world's first coronavirus vaccine" has been completed. The vaccine was developed by the Gamali Institute of Epidemiology and Microbiology and confirmed its safety, the report said.

"This is sufficient for the safety of vaccines currently on the market," said Alexander Lukashev, director of the Institute of Medical Parasitology, Tropical and Vector-Burn Diseases at Sechenov University.
Russian corona vaccine


Although many news reports claim that this is the first vaccine to complete human testing, the timeliness and purpose of the research indicates that it has been cleared or is still ongoing - the first phase of the investigation.


In vaccine tests, the first stage usually involves a small group aiming to test the safety of the vaccine for humans.


Subsequent stages rapidly expand the test and may be many years before the vaccine is scheduled for mass production. As a result, vaccines usually take 10–15 years to reach the market.

For the first phase, the U.S. Department of Health and Human Services said the phase "often takes place over a small group of healthy individuals (20 to 80) to diagnose their health and side effects and find the right dose of the drug." Tests experimental treatment. "



The Sechenov study is listed on ClinicalTrails.GO - Registry of Clinical Studies conducted by the U.S. National Library of Medicine - as a two-step trial of the drug gum-Kovid-Wac Leo.


Specifically, the registry lists the trial as an "open two-stage non-randomized phase 1 study with the participation of healthy volunteers". This clinical trial drug "Gum-Kovid-Wac Leo" is an open study of safety, tolerance and immunogenicity., Lyophilisate for a solution for intramuscular administration with the participation of healthy volunteers.

russian coronavirus vaccines
russian coronavirus vaccines




Russian corona virus vaccine

Similarly, a World Health Organisation document on 'Draft landscape of COVID-19 candidate vaccines' lists two trials by the Gamaleya Research Institute as being Phase-I trials.

Russian coronavaccine

Russia is working on 17 vaccines for the coronavirus, according to the country's health minister on July 8. In June, Dpty. Prime Minister D.Chernashenko said, ''that mass vaccinations could be carried out in the fall, although these would be voluntary.''


According to the Sechenov University website, volunteers, both male and female and 18-65 year olds, received the lyophilized vaccine for the vaccine, which was developed by the Gamalaya Institute.


The Sputnik report, citing Alexander Lukashev, director of the Institute of Medical Parapsychology, Tropical and Vector-Burn Diseases at Sechenov University, said the study was intended to demonstrate the vaccine's safety in humans,  it was successfully completed .


Vadim Tarasov, director of the Institute for Translational Medicine and Biotechnology, said clinical trials for the vaccine were currently underway.


Skoilarchuk, head of the Center for Clinical Research on Medicine at Sechinov University, said volunteers are under medical supervision as patients after discharge.


Earlier, on June 30, researchers said they had not seen any adverse effects of the vaccine on the active cases.
“Tests are conducted regularly without serious adverse reactions.

There are some side effects that are directly related to the vaccine. This is the so-called systemic and local post-vaccine reaction, which is mild and disappears on its own without additional measures. Volunteers are in good health, ”Smolarchuk told Tas‌ at the time.

Earlier, on July 10, the Russian Ministry of Defense stated that volunteers were well vaccinated, had no complaints, no side effects, and increased immunity to coronaviruses, TASS reported. The first and second groups are developing an immune response after being vaccinated, the Ministry of Defense said.

Russian corona vaccine

The July 10 report concludes that the trial, along with 15 other volunteers, will end on July 15 as part of a program to "strengthen the immune system and strengthen their endurance". Let's get to the second half. The report states.


In addition, a June 22 report published by Sputnik News quoted Gamalaya director Alexander Gintesberg as saying the vaccine would protect people from the virus for more than two years.



Russia, the fourth country affected by the coronavirus novel, has 727,000 cases and more than 11,000 deaths. While the number of new cases daily dropped to the summit in May, the country began reducing borders at stores, public transportation, medical facilities and others in Moscow, with forced marches to reduce areas from July 14. Requirements. ''

Currently, according to the WHO list, Synovac and the University of Oxford / AstraZeneca are the only vaccines to reach the third phase of testing on July 7 in China. It has partnered with the world's largest vaccine maker, the Serum Institute of India. The University of Oxford recently stated that the safest vaccine for at least six months would not produce a vaccine.


Moscow became the first country in Russia to complete clinical trials of human immunodeficiency virus, and the result was drug-like, media reported Sunday.



Elena Smolyaruk, chief investigator at the Center for Clinical Research on Medicine at the University of Sechinov, told Russian news agency TAZ on Sunday that human immunization tests had been completed at the university and would be released soon.



In a statement to Whitechuk, he said, "The study has been completed and the vaccine has been found to be safe. Volunteers will be released on July 15 and July 20."



However, no further details were provided regarding the entry into the commercial production category.



Russia has approved two clinical trials for coronavirus vaccine launched on June 18 by the Gamalaya National Research Center for Epidemiology and Microbiology.



The first vaccine as a solution for intramuscular administration was given at Burdenko Military Hospital.



Another vaccine for the form of powder for the preparation of intramuscular control solution was given at Sechenov First Mos State State Medical University.



A team of 18 volunteers and a team of 20 volunteers will participate in the first vaccination phase at the University of Siknov.



After vaccination, all volunteers are expected to be hospitalized on their own for 28 days.



Earlier, trials of coronavirus vaccines conducted in a group of Russian volunteers showed that they increased the risk of coronaviruses.



An earlier statement from the Russian Ministry of Defense stated, "Data from the Gamal National Research Center for Epidemiology and Microbiology shows that volunteers in the first and second groups received an immune response after being vaccinated against coronavirus."



Russia has reported 719,449 cases of coronavirus and 11,188 deaths so far.

Russian corona vaccine



There are at least 21 vaccines currently under key trials, according to the WHO.


The overall number of global COVID-19 cases was nearing 12.7 million, while the deaths have increased to more than 564,000, according to Johns Hopkins University in the US.


As of Sunday morning, the total number of new cases are at 12,681,472, while the death patients are to 564,420.


As the US counted for the world's highest number of corona infected peoples and deaths are at 3,245,158 and 134,764. Also the Brazil came in the 2nd place with 1,839,850 infections patients and 71,469 deaths.


russian coronavirus vaccines
russian coronavirus vaccines


Russian corona vaccine


At a time when the world is struggling to control the spread of the highly contagious coronavirus caused by SARS - CoV - 2, Russia has developed the world's first vaccine against terrible infections.


 According to the news agency Sputnik, Sechinov of the University of Russia has completed development and successfully conducted all clinical trials of the vaccine, which is considered to be the first vaccine in the world against the novel coronaviruses.
 
The first successful treatment in Russia

Russia corona vaccine


Vadim Tarasovas, director of the Institute for Translational Medicine and Biotechnology, said that the clinical trials of the world's first COVID-19 vaccine on volunteers have been completed at Sechinov First Moscow State Medical University. And the second group will be released on July 20th.


Here is the coronavirus vaccine information set up at the University of Rosia.
Hope you all like it and share it with your friends and family.
Thank you.

sincerly,
Team,exactknow-how




Post a Comment

plz comment our blog and give us feed back and also give your raised questions to us.And you can contact us.

Previous Post Next Post